263 related articles for article (PubMed ID: 14993574)
1. Effectiveness and safety of tissue plasminogen activator in the management of complicated parapneumonic effusions.
Weinstein M; Restrepo R; Chait PG; Connolly B; Temple M; Macarthur C
Pediatrics; 2004 Mar; 113(3 Pt 1):e182-5. PubMed ID: 14993574
[TBL] [Abstract][Full Text] [Related]
2. Stratifying fibrinolytic dosing in pediatric parapneumonic effusion based on ultrasound grade correlation.
James CA; Braswell LE; Pezeshkmehr AH; Roberson PK; Parks JA; Moore MB
Pediatr Radiol; 2017 Jan; 47(1):89-95. PubMed ID: 27709281
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology.
Majid A; Ochoa S; Chatterji S; Fernandez-Bussy S; Kheir F; Rivera E; Cheng G; Folch E
Ann Am Thorac Soc; 2017 Mar; 14(3):342-346. PubMed ID: 28079399
[TBL] [Abstract][Full Text] [Related]
4. Management of complicated parapneumonic effusions in children.
Feola GP; Shaw LC; Coburn L
Tech Vasc Interv Radiol; 2003 Dec; 6(4):197-204. PubMed ID: 14767852
[TBL] [Abstract][Full Text] [Related]
5. Intrapleural alteplase decreases parapneumonic effusion volume in children more than saline irrigation.
Hanson SJ; Havens PL; Simpson PM; Nugent ML; Wells RG
Pediatr Pulmonol; 2015 Dec; 50(12):1328-35. PubMed ID: 25847131
[TBL] [Abstract][Full Text] [Related]
6. Intrapleural fibrinolysis for parapneumonic effusion and empyema in children.
Wells RG; Havens PL
Radiology; 2003 Aug; 228(2):370-8. PubMed ID: 12893898
[TBL] [Abstract][Full Text] [Related]
7. Urokinase in the management of complicated parapneumonic effusions in children.
Krishnan S; Amin N; Dozor AJ; Stringel G
Chest; 1997 Dec; 112(6):1579-83. PubMed ID: 9404757
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial.
Livingston MH; Mahant S; Connolly B; MacLusky I; Laberge S; Giglia L; Yang C; Roberts A; Shawyer A; Brindle M; Parsons S; Stoian C; Walton JM; Thorpe KE; Chen Y; Zuo F; Mamdani M; Chan C; Loong D; Isaranuwatchai W; Ratjen F; Cohen E
JAMA Pediatr; 2020 Apr; 174(4):332-340. PubMed ID: 32011642
[TBL] [Abstract][Full Text] [Related]
9. Parapneumonic pleural effusion and empyema.
Koegelenberg CF; Diacon AH; Bolliger CT
Respiration; 2008; 75(3):241-50. PubMed ID: 18367849
[TBL] [Abstract][Full Text] [Related]
10. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients.
Israel EN; Blackmer AB
Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857
[TBL] [Abstract][Full Text] [Related]
11. Treatment of complicated parapneumonic pleural effusion with intrapleural streptokinase in children.
Yao CT; Wu JM; Liu CC; Wu MH; Chuang HY; Wang JN
Chest; 2004 Feb; 125(2):566-71. PubMed ID: 14769739
[TBL] [Abstract][Full Text] [Related]
12. Mixing It Up: Coadministration of tPA/DNase in Complicated Parapneumonic Pleural Effusions and Empyema.
Bishwakarma R; Shah S; Frank L; Zhang W; Sharma G; Nishi SP
J Bronchology Interv Pulmonol; 2017 Jan; 24(1):40-47. PubMed ID: 27984384
[TBL] [Abstract][Full Text] [Related]
13. Intrapleural tissue plasminogen activator for complicated pleural effusions.
Skeete DA; Rutherford EJ; Schlidt SA; Abrams JE; Parker LA; Rich PB
J Trauma; 2004 Dec; 57(6):1178-83. PubMed ID: 15625447
[TBL] [Abstract][Full Text] [Related]
14. Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection. A Single-Center Experience.
Majid A; Kheir F; Folch A; Fernandez-Bussy S; Chatterji S; Maskey A; Fashjian M; Cheng G; Ochoa S; Alape D; Folch E
Ann Am Thorac Soc; 2016 Sep; 13(9):1512-8. PubMed ID: 27333122
[TBL] [Abstract][Full Text] [Related]
15. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.
Khemasuwan D; Sorensen J; Griffin DC
Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous management of complicated parapneumonic effusion and empyema after surgical tube thoracostomy failure in children: a retrospective study.
Turan Ciftci T; Akinci D; Unal E; Tanır G; Artas H; Akhan O
Diagn Interv Radiol; 2021 May; 27(3):401-407. PubMed ID: 34003128
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of intrapleural tissue-type plasminogen activator in the treatment of loculated parapneumonic effusions.
Zuckerman DA; Reed MF; Howington JA; Moulton JS
J Vasc Interv Radiol; 2009 Aug; 20(8):1066-9. PubMed ID: 19560940
[TBL] [Abstract][Full Text] [Related]
18. Implications of early sonographic evaluation of parapneumonic effusions in children with pneumonia.
Ramnath RR; Heller RM; Ben-Ami T; Miller MA; Campbell P; Neblett WW; Holcomb GW; Hernanz-Schulman M
Pediatrics; 1998 Jan; 101(1 Pt 1):68-71. PubMed ID: 9417153
[TBL] [Abstract][Full Text] [Related]
19. Trends in treatment of infectious parapneumonic effusions in U.S. children's hospitals, 2004-2014.
Dorman RM; Vali K; Rothstein DH
J Pediatr Surg; 2016 Jun; 51(6):885-90. PubMed ID: 27032611
[TBL] [Abstract][Full Text] [Related]
20. Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic Effusions.
Arnold DT; Hamilton FW; Elvers KT; Frankland SW; Zahan-Evans N; Patole S; Medford A; Bhatnagar R; Maskell NA
Am J Respir Crit Care Med; 2020 Jun; 201(12):1545-1553. PubMed ID: 32069085
[No Abstract] [Full Text] [Related]
[Next] [New Search]
